Micardis HCT 40-12.5 MG tablet UD 30S
Ended Awarded
- Contract number
- SPE2DB25FY8YL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,001
Award facts
- Contract value 100% obligated
- $4,000.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price delivery order has a ceiling value of $4,000.64 and an ultimate completion date of August 7, 2025. The contract utilizes AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania.
This delivery order represents a routine pharmaceutical procurement under DLA's Medical Supply Chain operations, which leverage AmerisourceBergen's role as a major pharmaceutical distributor serving military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a child contract under the SPE2DX IDC, this award exemplifies the flexibility of the indefinite delivery vehicle in supporting the Defense Health Agency and other federal healthcare customers with rapid access to critical pharmaceutical products on an as-needed basis.
Quick answers
Who was awarded contract SPE2DB25FY8YL?
SPE2DB25FY8YL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FY8YL worth?
The government has obligated $4,001 on SPE2DB25FY8YL.
Is contract SPE2DB25FY8YL an order under another contract?
Yes. SPE2DB25FY8YL is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8YL competed?
The extent of competition for SPE2DB25FY8YL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award